Analysis Of Income And Expense [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Analysis of income and expense [abstract] | ||
| Revenue [abstract] | ||
| Revenue |
27,549
EUR
|
26,259
EUR
|
| Material income and expense [abstract] | ||
| Impairment loss (reversal of impairment loss) on trade receivables [abstract] | ||
| Impairment loss recognised in profit or loss, trade receivables |
98,000
EUR
|
125,000
EUR
|
| Finance income (cost) |
960,000
EUR
|
622,000
EUR
|
| Operating expense |
25,709
EUR
|
24,509
EUR
|
| Expenses by nature [abstract] | ||
| Classes of employee benefits expense [abstract] | ||
| Employee benefits expense |
15,135
EUR
|
12,965
EUR
|
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||
| Depreciation and amortisation expense [abstract] | ||
| Depreciation expense |
270,000
EUR
|
181,000
EUR
|
| Amortisation expense |
2,352
EUR
|
2,212
EUR
|
| Other expenses, by nature |
3,880
EUR
|
3,112
EUR
|
| Disclosure of attribution of expenses by nature to their function [text block] | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||
| Disclosure of attribution of expenses by nature to their function [line items] | ||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||
| Share of profit (loss) of associates and joint ventures accounted for using equity method |
7,000
EUR
|
87,000
EUR
|
| Comprehensive income, continuing and discontinued operations [abstract] | ||
| Comprehensive income |
688,000
EUR
|
287,000
EUR
|